|
|
|
| Application of combined test of serum C-peptide,glycosylated hemoglobin and N-acetylβ-D-glucosidase in the diagnosis of early renal injury of type 2diabetesmellitus |
| ZHONG Xiao-xiong |
| Clinical Laboratory,Guangzhou First People′s Hospital,Guangdong Province,Guangzhou 510180,China |
|
|
|
|
Abstract Objective To investigate the application of combined test of serum C peptide,glycosylated hemoglobin and N-acetylβ-D-glucosidase in the diagnosis of early renal injury in type 2diabetesmellitus.Methods A total of 50 patientswith early renal injury of type 2diabetesmellitus treated in our hospital from January 2018 to June 2019 were selected as the study group.Another 50 patientswith type 2diabetesmellitus treated in our hospital in the same period of time were selected as the control group 1.In addition,50 volunteers who came to the hospital for routine physical examination in the same time period were selected as the control group 2.All the three groupswere diagnosed by combined test of serum C-peptide,glycosylated hemoglobin and N-acetylβ-D-glucosidase,and the resultswere compared and analyzed.Results The course of diabetes in the study group was longer than that in the control group 1,and the differencewas statistically significant(P＜0.05).The levels of fasting blood glucose and urinarymicroalbumin to creatinine in the study group were higher than those in the control group,and the differences were statistically significant(P＜0.05).The levels of glycosylated hemoglobin and N-acetylβ-D-glucosidase in the study group were higher than those in the control group 1and control group 2,and the differenceswere statistically significant(P＜0.05).The levels of serum C-peptide in the study group was lower than that in the control group 1and control group 2,the difference was statistically significant(P＜0.05).The levels of fasting blood glucose and urinarymicroalbumin/creatine ratio in the control group 1were higher than those in the control group 2,and the differenceswere statistically significant(P＜0.05).The levels of of hemoglobin,N-acetylβ-D-glucosidase in the control group 1were higher than those of the control group 2,and the difference was statistically significant(P＜0.05).The level of serum C-peptide in the control group 1was lower than that in control group 2,and the difference was statistically significant(P＜0.05).Conclusion The combined test of serum C-peptide,glycosylated hemoglobin and N-acetylβ-D-glucosidase can play an effective role in the diagnosis of early diabetic renal injury.It can provide an accurate reference for the diagnosis of diabetesmellitus,and has important application value.
|
|
|
|
|
|
| [1] |
阿里同彩次克，马艳荣.血清C肽与糖化血红蛋白联合检验对糖尿病的诊断价值分析[J].糖尿病天地，2019，16（9）：101.
|
| [2] |
杨晓樨，马吉芳，王镱达，等.血清C肽与糖化血红蛋白检验诊断糖尿病的临床效果[J].航空航天医学杂志，2019，30（9）：1052-1053.
|
| [3] |
刘建华.血清C肽与糖化血红蛋白联合检验诊断糖尿病的意义分析[J].糖尿病天地，2019，16（9）：11-12.
|
| [4] |
王艳荣.血清C肽与糖化血红蛋白联合检验在糖尿病诊断中的作用评价[J].国际医药卫生导报，2019，25（16）：2690-2692.
|
| [5] |
王霞.血清C肽联合HbA1c检验诊断糖尿病患者的价值研究[J].糖尿病新世界，2019，22（15）：55-56.
|
| [6] |
周晓辉.血清C肽与糖化血红蛋白联合检验对糖尿病的诊断价值分析[J].首都食品与医药，2019，26（7）：78.
|
| [7] |
张丽梅.血清C肽与糖化血红蛋白检验用于糖尿病诊断的效果分析[J].深圳中西医结合杂志，2019，29（15）：69-71.
|
| [8] |
王建民.血清C肽与糖化血红蛋白联合检验诊断糖尿病的临床效果评价[J].智慧健康，2019，5（21）：58-59.
|
| [9] |
郭娜.血清C肽、糖化血红蛋白在糖尿病诊断中的临床意义[J].河南医学研究，2019，28（12）：2264-2265.
|
| [10] |
汪作新.血清C肽与糖化血红蛋白检验对糖尿病诊断的临床意义[J].中外医学研究，2019，17（11）：65-67.
|
| [11] |
Li Y，Zhou HM，Li YL，et al.PTPN2improved renal injury and fibrosis by suppressing STAT-induced inflammation in early diabetic nephropathy[J].JCell Mol Med，2019，23（6）：4179-4195.
|
| [12] |
Kelly CB，Hookham MB，Yu JY，et al.Subclinical first trimester renalabnormalitiesare associated with preeclampsia in normoalbuminuric women with type 1diabetes[J].Diabetes Care，2018，41（1）：120-127.
|
| [13] |
孟凡飞，刘萍，杨聚豪，等.HbA1c、C肽和尿NAG对2型糖尿病早期肾损伤的诊断价值[J].检验医学，2017，32（11）：1031-1035.
|
| [14] |
高娇，肖敏，李丹，等.尿肾功能指标在糖尿病肾病早期肾损伤中的评估价值[J].医学临床研究，2019，36（5）：843-845.
|
| [15] |
刘灵燕，钟政荣，陈福祥.尿微量蛋白对2型糖尿病早期肾损伤的诊断价值[J].山西医科大学学报，2017，48（1）：40-43.
|
| [16] |
戴婉如，游若兰，周欢.尿液N-乙酰-β-D-氨基葡萄糖苷酶和视黄醇结合蛋白在早期肾损伤中的临床价值[J].医学检验与临床，2018，29（1）：14-18.
|
| [17] |
沈丽莎，彭文芳，夏莉莉，等.2型糖尿病肾病患者血清Kim-1、尿NAG、AGT水平的表达及临床意义[J].实用预防医学，2018，25（10）：1252-1255.
|
|
|
|
